JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Internal Medicine Section DOI : 10.7860/JCDR/2021/46961.14615
Year : 2021 | Month : Mar | Volume : 15 | Issue : 03 Full Version Page : OC09 - OC13

Diagnostic Validity of Computed Tomography Thorax in Comparison with Fibreoptic Bronchoscopy for Endobronchial Lesions

S Mamatha1, Alamelu Haran2, S Ashwini3, Ranganath T Ganga4, H Ajit5

1 Assistant Professor, Department of Respiratory Medicine, Vydehi Institute of Medical Sciences and Research Centre, Rajiv Gandhi Institute of Health Sciences, Bangalore, Karnataka, India.
2 Professor and Head, Department of Respiratory Medicine, Vydehi Institute of Medical Sciences and Research Centre, Rajiv Gandhi Institute of Health Sciences, Bangalore, Karnataka, India.
3 Associate Professor, Department of Community Medicine, Sri Dharmasthala Manjunatheshwara University, Dharwad, Karnataka, India.
4 Assistant Professor, Department of Pulmonary Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
5 Assistant Professor, Department of Respiratory Medicine, Vydehi Institute of Medical Sciences and Research Centre, Rajiv Gandhi Institute of Health Sciences, Bangalore, Karnataka, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: S Mamatha, No. 110, 14th Main, 1st Block, HMT Layout, Vidyaranyapura, Bangalore-560097, Karnataka, India.
E-mail: dr.mamatha3@gmail.com
Abstract

Introduction

Fibreoptic Bronchoscopy (FOB) is the gold standard for diagnosis of endobronchial diseases, an invasive procedure not without risks. Computed Tomography (CT) illustration of thoracic anatomy provides guidance in sampling procedure for diagnosis of endobronchial disease through FOB. Yet, in real life scenario, we find discrepancy between findings of CT and bronchoscopy which necessitates the patients to undergo divond invasive procedure for a definitive diagnosis.

Aim

To assess the diagnostic validity of CT imaging in diagnosing endobronchial diseases by comparing with FOB findings and to correlate FOB findings with pathological results.

Materials and Methods

This was a cross-divtional retrospective analysis over six years in a tertiary care centre from January 2012 to December 2018. The findings on CT and FOB were classified as normal, abnormal mucosa, mass and extrinsic compression. FOB samples were sent for pathological examination.

Results

A total of 426 patients were included in the study. The sensitivity of CT for presence of normal bronchus, abnormal mucosa, mass and extrinsic compression was 93.03%, 27.50%, 89.00% and 59.52% and specificity was 91.76%, 98.45%, 89.88% and 94.79%, respectively. Pathological diagnosis was obtained in 135 (97.12%) out of 139 cases. Squamous cell carcinoma was the most common 62 (41.01%) histological diagnosis.

Conclusion

Computed Tomography (CT) thorax imaging has good sensitivity and specificity to detect endobronchial mass but has poor sensitivity for detection of extrinsic compression and mucosal abnormalities in bronchi. Squamous cell carcinoma was the most common pathological diagnosis.

Keywords

Introduction

The Fibreoptic Bronchoscopy (FOB) is a gold standard tool for visualisation and definitive diagnosis of endobronchial lesions [1,2]. Computed Tomography (CT) prior to FOB provides a roadmap to bronchoscopist to target endobronchial lesions [3]. In clinical practice, those patients who had mismatch between FOB and CT image findings had to undergo further invasive procedure to obtain correct diagnosis. This study compared radiologist’s perspective of CT thorax image findings with that of pulmonologist’s finding at bronchoscopy. Present study was done to evaluate the type of lesions not accurately identified by CT. This will enable bronchoscopists to be more vigilant while planning for diagnostic procedures and prevent repeated invasive investigations, the associated risks and cost. The primary outcome of the study was to analyse the disparity between findings of CT thorax and FOB and secondary outcome was to assess the diagnostic yield of samples obtained by FOB.

Materials and Methods

This study is a cross-sectional retrospective study done in a Tertiary Care Centre in Vydehi Institute of Medical Sciences and Research Centre, Bangalore, India from January 2012 to December 2018. Details were collected from medical records after the study was approved by the Institutional Ethical Committee (EC No. -VIEC/2019/APP/035).

Inclusion criteria: Patients who underwent CT thorax followed by bronchoscopy during January 2012 to December 2018.

Exclusion criteria: Patients who did not undergo CT thorax in our institution.

The number of patients included in the study was 426. Clinical history, clinical examination and details of relevant investigations done were collected. CT thorax was performed for all patients with helical CT with 5 mm cuts with multiplanar reconstruction using Siemen’s SOMATOM definition AS (128 slice), model no. 240 (10141785), Germany, single breath hold, 0.6 mm collimation, 1.2 pitch, 1 mm reconstruction, 80-120 kVp, 90-260/300 mA spanning from T1 vertebra to the domes of diaphragm. Contrast CT was performed using 1 mL/kg of Omnipaque. 352 (82.62%) patients underwent Contrast Enchanced CT (CECT) thorax. With 128 slice images and proper breath-hold technique, all the images were assessed for quality. Two experienced radiologists independently reviewed the reports and a common consensus was reported. FOB was performed using Olympus BF type 1T 150 (Tokyo, Japan). The endobronchial findings on CT thorax imaging and FOB were recorded as normal bronchus, abnormal mucosa, endobronchial mass and extrinsic compression of bronchus. The findings were noted from CT reports and bronchoscopy procedure notes described in records. Cytological and/or histological reports were collected from bronchoscopy register. Working case definitions used in the study were as per [Table/Fig-1] [4-6]. If findings were equivocal, the predominant finding of CT imaging and bronchoscopy were noted. The findings of CT thorax imaging were compared with that of FOB. Bronchoalveolar Lavage (BAL), Endobronchial Biopsy (EBB), and Transbronchial Node Aspiration (TBNA) were done as per case to case basis. EBB was done using Olympus biopsy forceps (Model No. FB-19CR-1). TBNA was done using eXcelon transbronchial aspiration needle (Boston Scientific, Spencer, USA). Accordingly samples obtained from FOB were sent for pathological examination and relevant cultures.

Working case definitions used in the study [4-6].

Definition in studyCT thoraxBronchoscopy
1. Abnormal mucosaMucosal nodularity- diffuse/focal.The presence of one or more of the following findings on FOB- mucosal oedema, mucosal erythema, mucosal friability, mucosal irregularity and loss of bronchial mucosal markings.
2. MassPartial or complete occlusion of bronchial lumen and/or the presence of bronchus cut-off sign.Presence of an endobronchial growth completely or partly occluding the bronchial lumen.
3. Extrinsic compressionCompression of the bronchus due to surrounding anatomical structures without evidence of mucosal involvement.Bronchial narrowing due to compression of bronchial lumen from surrounding structures and visualised mucosa is apparently normal.

The pathological diagnosis included malignancy, infections, inflammatory lesions and miscellaneous diseases. The pathological typing of lung cancer was classified as per World Health Organisation (WHO) [7].

Statistical Analysis

Statistical analysis was done using SPSS 18.0 version (IBM Inc., Armonk, New York, USA). Sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV), diagnostic accuracy, likelihood ratio of a positive test and negative test and Kappa co-efficient were calculated comparing CT thorax imaging with FOB. Yield of EBB and transbronchial node aspiration were represented in percentages.

Results

This study included 426 patients out of which 309 (72.53%) were males and 117 (27.47%) were females. The male:female ratio in the study was 2.6:1. 277 (65.02%) were smokers, out of which 274 (98.91%) were males and 3 (1.08%) were females. Demographic characteristics and indications for performing FOB have been shown in [Table/Fig-2].

Demographic characteristics, presenting complaints of patients and indications for performing FOB.

CharacteristicsNumber (%)
Males309 (72.53%)
Females117 (27.47%)
Mean age (years)49.4
Smokers277(65.02%)
Presenting complaints
Cough246 (57.74%)
Breathlessness232 (54.46%)
Chest pain217 (50.93%)
Hemoptysis149 (34.97%)
Fever162 (38.02%)
Loss of appetite and weight254 (59.62%)
Indications of FOB
Suspected infection154 (36.15%)
Suspected malignancy252 (59.57%)
Interstitial lung disease9 (2.11%)
Atelectasis8 (1.87%)
Administration of drugs3 (0.70%)

On CT thorax, normal bronchus, abnormal mucosa [Table/Fig-3], endobronchial mass [Table/Fig-4] and extrinsic compression [Table/Fig-5] was found in 242 (56.80%), 17 (3.99%), 122 (28.63%) and 45 (10.56%) patients respectively. Among findings on FOB, normal bronchus, abnormal mucosa [Table/Fig-6], endobronchial mass [Table/Fig-8] and extrinsic compression [Table/Fig-7] was found in 244 (57.27%), 40 (9.3%), 100 (23.47%) and 42 (9.85%) patients respectively [Table/Fig-9]. CT thorax imaging and bronchoscopy reports of 426 patients were compared. The sensitivity of CT for presence of normal bronchus, abnormal mucosa, endobronchial mass and extrinsic compression was 93.03%, 27.50%, 89.00% and 59.52% and specificity was 91.76%, 98.45%, 89.88% and 94.79% respectively [Table/Fig-9].

CT thorax image showing right endobronchial irregularity (Red arrow).

CT thorax image showing right main bronchus “cut-off” sign (Red arrow).

CT thorax image showing extrinsic compression of left main bronchus (Red arrow).

FOB showing irregular(cobble-stone) appearance of endobronchial mucosa (Red arrow).

FOB showing extrinsic compression of bronchus (Red arrow).

FOB showing endobronchial mass lesion (Red arrow).

Diagnostic validity of CT thorax versus FOB in identification of normal bronchus, abnormal mucosa, endobronchial mass and extrinsic compression.

Normal FOBAbnormal FOBSensitivitySpecificityPositive predictive valueNegative predictive value
CT imaging
Bronchus
Normal2271593.03%91.76%93.8%90.76%
Abnormal17167
Total244182
Abnormal bronchusPresent on FOBAbsent on FOB
1) Abnormal mucosa
Present11627.5%98.45%64.71%92.91%
Absent29380
Total40386
2) Endobronchial mass
Present893389%89.88%72.95%96.38%
Absent11293
Total100326
3) Extrinsic compression
Present252059.52%94.79%55.56%95.54%
Absent17364
Total42384

Patients with abnormal bronchial mucosa (40) and endobronchial mass (100) were subjected to EBB [Table/Fig-9]. Bronchoscopic biopsy was deferred in one patient due to spontaneous bleed from the lesion. Hence, 139 (32.62%), 22 (5.16%) and 211 (49.53%) cases underwent EBB, TBNA and BAL respectively. Out of 22 TBNA cases, 19 were from station seven (subcarinal lymph node) and three from station 4R (right paratracheal lymph node). Out of 139 EBB done, pathological diagnosis was obtained in 135 (97.12%) [Table/Fig-10]. Transbronchial node aspiration yielded results in 12 (54.54%) of 22 cases. The most common pathological finding was malignancy in patients who were subjected for EBB. The most common malignancy was squamous cell carcinoma in 43 (26.54%) patients followed by adenocarcinoma in 32 (19.75%) patients and non-small cell carcinoma (not otherwise specified) in 22 (13.58%) patients [Table/Fig-10].

Pathological diagnosis of lesions detected on FOB.

Pathological diagnosisAbnormal mucosa (%)Endobronchial mass (%)Transbronchial node aspiration (%)
Adenocarcinoma11 (27.50%)19 (19.00%)2 (9.09%)
Squamous cell carcinoma11 (27.50%)30 (30.00%)2 (9.09%)
Small cell carcinoma5 (12.50%)8 (8.00%)0
Non- small cell carcinoma (not otherwise specified)3 (7.50%)18 (18.00%)1 (4.54%)
Poorly differentiated carcinoma5 (12.50%)8 (8.00%)1 (4.54%)
Inconclusive1 (2.50%)3 (3.00%)12 (54.54%)
Miscellaneous tumours3 (7.50%)7 (7.00%)0
Infections06 (6.00%)0
Inflammation1 (2.50%)04 (18.18%)
Deferred01 (1.00%)0
Total4010022

Discussion

Despite an era of rapidly progressing interventional pulmonology, there is no substitute till date to initial assessment of bronchial tree by CT thorax. Present study compared radiologist’s perspective of CT thorax endobronchial findings with that of pulmonologist’s finding on bronchoscopy. Disparity between endobronchial findings of CT thorax and FOB have been noted in day to day practice. Hence, this study was designed to shed light on the diagnostic validity of CT in the epoch of advanced CT imaging, by comparing it with findings on FOB in identifying endobronchial lesions.

Computed Tomography is the first investigation when endobronchial disease is suspected clinically and on chest radiograph, before fibre-optic bronchoscopy. CT thorax helps to increase the diagnostic yield of bronchoscopy by targeting the suspicious lesions, staging in cases of malignancy and follow-up of patients [8-10]. CT helps in detection of extraluminal abnormalities and detection of distant disease which is not visualised on FOB [11,12]. FOB is the gold standard for the investigation of endobronchial diseases [1,2]. FOB allows direct visualization of tracheo-bronchial tree and to collect biological specimens from suspicious areas thereby helping in establishment of diagnosis. It is also useful for staging of lung malignancies [8].

The present study was an attempt to know the type of lesions which are misinterpreted on CT scan, so that pulmonologists could be more careful while selecting patients for bronchoscopy and it’s related interventions. CT imaging done prior to FOB will guide the bronchoscopist regarding the need of subjecting the patient for FOB depending on the bronchoscopic accessibility of the lesion and if accessible, to know the most appropriate technique to achieve sample for definitive diagnosis. As per Laroche C et al., performing bronchoscopy after CT scan of thorax improved the accuracy of diagnosis significantly, avoids an invasive procedure in 7% of patients and prevents another invasive investigation in 10% of patients [8]. FOB is usually an effective and safe procedure, yet it is not without any complications especially in the debilitated, elderly and those with co-morbidities such as obstructive airway diseases and cardiac diseases [13]. The attributable mortality rate of fibreoptic bronchoscopy has been <0.1%-0.5% and complication rate has been 0.739% and 0.5-0.8% [6,12,14-18]. Therefore, appropriate selection of patients for bronchoscopy would avoid not only the discomfort, cost and complications of an invasive procedure like bronchoscopy but also prevent the brunt of second invasive procedure to achieve the diagnosis if bronchoscopy is inconclusive.

Naidich DP et al., did a retrospective study with a sample size of 102 patients and concluded that there is good overall statistical correlation between axial CT and FOB in identification of focal bronchial abnormality [5]. Out of 64 cases, 59 who were earlier diagnosed as abnormal on CT were confirmed on performing FOB. CT predicted normal bronchus in 35 out of 38 cases which were normal on FOB. The authors inferred that axial CT was inaccurate in predicting whether a given focal abnormality will be endobronchial, submucosal or extrinsic [5].

Finkelstein SE et al., studied on 44 patients and inferred sensitivity of super high-resolution CT in predicting mucosal abnormality, mass and extrinsic compression was 16%, 90% and 100%, respectively, while present study showed the sensitivity of CT for presence of normal bronchus, abnormal mucosa, mass and extrinsic compression was 93.03%, 27.50%, 89.00% and 59.52%, respectively. Authors did not mention about specificity of CT with respect to type of endobronchial lesions. CT sensitivity to detect extrinsic compression was 100% against the present study value of 59.52%. This disparity could be due to large variation in sample size between present study and of Finkelstein et al. [19].

One finding common between present study and those of Naidich DP et al., and Finkelstein SE et al., is sensitivity of CT imaging in predicting mucosal abnormalities is low [5,19].

As per study done by Lee et al., with respect to location of the lesion (submucosal, endobronchial or peribronchial), in 23 (77%) out of 30 patients FOB corresponded with CT [2].

Present study showed overall PPV of 93.8%, NPV of 90.76% and diagnostic accuracy of 92.49% of CT thorax in detection of endobronchial disease. Bungay HK et al., in their study revealed PPV of 85% and NPV of 78% of axial CT in detection of endobronchial mass lesion. Overall better PPV and NPV in present study are probably due to usage of advance CT imaging. Bungay HK et al., did not take into consideration abnormal mucosa and extrinsic compression of bronchus. They found sensitivity of 60.6% and specificity of 86.2% in detection of endobronchial mass by CT [12].

The secondary outcome of the present study was to analyse the pathological diagnosis of samples and conclusive result was achieved in 135 (97.12%) of 139 cases. Though bronchoscopy is an operator-dependent procedure which has led to success rate of diagnosis of lung cancer varying between 50-86%, present study achieved diagnosis in 97.12% of cases [12,20,21]. In present study, 43 (26.54%) of patients had squamous cell carcinoma followed by adenocarcinoma in 32 (19.75%) patients and non-small cell carcinoma (not otherwise specified) in 22 (13.58%) patients. Higher percentage of squamous cell carcinoma presenting as endoscopically visible growth was also seen in studies done by Gao L et al., Kumar V et al., and Parvathi BKL et al. [22-24].

To our best knowledge after literature search, present is the only study with a large sample size of 426 patients done exclusively by pulmonologists till now to evaluate the discrepancy between CT and FOB.

Limitation(s)

It is a retrospective study done in a single centre and the exact time interval between CT thorax scan and FOB could not be retrieved from records.

Conclusion(s)

CT thorax imaging has good sensitivity and specificity to detect endobronchial mass but has poor sensitivity for detection of extrinsic compression and mucosal abnormalities in bronchi. Squamous cell carcinoma was the most common pathological diagnosis.

Future research direction is to do a large scale prospective study assessing whether advanced CT imaging techniques inclusive of real-time virtual bronchoscopy (VB) with FOB provides guidance to pulmonologists regarding best sampling technique to achieve diagnosis.

References

[1]Koletsis EN, Kalogeropoulou C, Prodromaki E, Kagadis GC, Katsanos K, Spiropoulos K, Tumoral and non-tumoral trachea stenoses: Evaluation with three-dimensional CT and virtual bronchoscopy J Cardiothorac Surg 2007 2:1810.1186/1749-8090-2-1817430592  [Google Scholar]  [CrossRef]  [PubMed]

[2]Jose RJ, Shaefi S, Navani N, Sedation for flexible bronchoscopy: Current and emerging evidence European Respiratory Review 2013 22:106-116.10.1183/09059180.0000641223728864  [Google Scholar]  [CrossRef]  [PubMed]

[3]Lee KS, Yoon JH, Kim TK, Kim JS, Chung MP, Kwon OJ, Evaluation of tracheobronchial disease with helical CT with multiplanar and three-dimensional reconstruction: Correlation with bronchoscopy RadioGraphics 1997 17:555-67.10.1148/radiographics.17.3.91536969153696  [Google Scholar]  [CrossRef]  [PubMed]

[4]Prince JS, Duhamel DR, Levin DL, Harrell JH, Friedman PJ, Nonneoplastic lesions of the tracheobronchial wall: Radiologic findings with bronchoscopic correlation RadioGraphics 2002 22(Suppl 1):S215-30.10.1148/radiographics.22.suppl_1.g02oc02s21512376612  [Google Scholar]  [CrossRef]  [PubMed]

[5]Naidich DP, Lee JJ, Garay SM, DI McCauley, CP Aranda, Boyd AD, Comparison of CT and fiberoptic bronchoscopy in the evaluation of bronchial disease AJR 1987 148:01-07.10.2214/ajr.148.1.13491497  [Google Scholar]  [CrossRef]  [PubMed]

[6]Gaeta M, Russi EG, La Spada F, Barone M, Casablanca G, Pandolfo I, Small bronchogenic carcinomas presenting as solitary pulmonary nodules. Bioptic approach guided by CT-positive bronchus sign Chest 1992 102(4):1167-70.10.1378/chest.102.4.11671395762  [Google Scholar]  [CrossRef]  [PubMed]

[7]Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, WHO classification of tumours of the lung, pleura, thymus and heart 2015 4th editionLyon (France)IARC Press  [Google Scholar]

[8]Laroche C, Fairbairn I, Moss H, Pepke-Zaba J, Sharples L, Flower C, Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer Thorax 2000 55:359-63.10.1136/thorax.55.5.35910770815  [Google Scholar]  [CrossRef]  [PubMed]

[9]Hansell DM, Boiselle PM, Goldin J, Kauczor HU, Lynch DA, Mayo JR, Patz EF Jr, Thoracic Imaging Respirology 2010 15(3):393-400.10.1111/j.1440-1843.2009.01698.x20136737  [Google Scholar]  [CrossRef]  [PubMed]

[10]Wynants J, Stroobants S, Dooms C, Vansteenkiste J, Staging of lung cancer Radiol Clin North Am 2007 45:609-25.10.1016/j.rcl.2007.05.00117706526  [Google Scholar]  [CrossRef]  [PubMed]

[11]Jose F, Aristizabal K, Young R, Nath N, Can chest CT decrease the use of preoperative bronchoscopy in the evaluation of suspected bronchogenic carcinoma? Chest 1998 113:1244-49.10.1378/chest.113.5.12449596301  [Google Scholar]  [CrossRef]  [PubMed]

[12]Bungay HK, Pal CR, Davies CW, Davies CW, Davies RJ, Gleeson FV, An evaluation of computed tomography as an aid to diagnosis in patients undergoing bronchoscopy for suspected bronchial carcinoma Clin Radiol 2000 55(7):554-603.10.1053/crad.2000.048510924381  [Google Scholar]  [CrossRef]  [PubMed]

[13]Fulkerson WJ, Current concepts: Fiberoptic bronchoscopy N Engl J Med 1984 311:511-15.10.1056/NEJM1984082331108066749209  [Google Scholar]  [CrossRef]  [PubMed]

[14]Mayr B, lngrisch H, Häussinger K, Huber RM, Sunder-Plassmann L, Tumors of the bronchi: Role of evaluation with CT Radiology 1989 172:647-52.10.1148/radiology.172.3.27721712772171  [Google Scholar]  [CrossRef]  [PubMed]

[15]Naidich DP, Sussman R, Kutcher WL, Aranda CP, Garay SM, Ettenger NA, Solitary pulmonary nodules: CT-bronchoscopic correlation Chest 1988 93:595-98.10.1378/chest.93.3.5953342671  [Google Scholar]  [CrossRef]  [PubMed]

[16]David L Stahl, Kathleen M Richard, Papadimos TJ, Complications of bronchoscopy: A concise synopsis Int J Crit Illn Inj Sci 2015 5(3):189-95.10.4103/2229-5151.16499526557489  [Google Scholar]  [CrossRef]  [PubMed]

[17]Jin F, Mu D, Chu D, Fu E, Xie Y, Liu T, Severe complications of bronchoscopy Respiration 2008 76(4):429-33.10.1159/00015165618716395  [Google Scholar]  [CrossRef]  [PubMed]

[18]Pue CA, Pacht ER, Complications of fiberoptic bronchoscopy at a university hospital Chest 1995 107:430-32.10.1378/chest.107.2.4307842773  [Google Scholar]  [CrossRef]  [PubMed]

[19]Finkelstein SE, Schrump DS, Nguyen DM, Hewitt SM, Kunst TF, Summers RM, Comparative evaluation of super high-resolution CT scan and virtual bronchoscopy for the detection of tracheobronchial malignancies Chest 2003 124(5):1834-40.10.1378/chest.124.5.183414605057  [Google Scholar]  [CrossRef]  [PubMed]

[20]Radke JR, Conway WA, Eyler WR, Kvale PA, Diagnostic accuracy in peripheral lung lesions Chest 1979 76:176-79.10.1378/chest.76.2.176456057  [Google Scholar]  [CrossRef]  [PubMed]

[21]Minami H, Ando Y, Nomura F, Sakai S, Shimokata K, Interbronchoscopist Variability in the diagnosis of lung cancer by flexible bronchoscopy Chest 1994 105:1658-62.10.1378/chest.105.6.16588205857  [Google Scholar]  [CrossRef]  [PubMed]

[22]Gao L, Asmitanand T, Ren H, Wu F, Zhang Y, Li X, Fiber-optic bronchoscope and detection of lung cancer: A five year study Neoplasma 2012 59(2):201-06.10.4149/neo_2012_02622248278  [Google Scholar]  [CrossRef]  [PubMed]

[23]Kumar V, Gupta KB, Aggarwal R, Yield of different bronchoscopic techniques in diagnosis of lung cancer Int J Res Med Sci 2017 5(9):4098-103.10.18203/2320-6012.ijrms20173990  [Google Scholar]  [CrossRef]

[24]Parvathi BKL, Sharma S, Lakshmee YB, Khan K, Yadav GS, Rajawat GS, Koolwal S, Bronchogenic Carcinoma: Endoscopy versus Histopathology J Clin Diagn Res 2020 14(8):OC19-24.10.7860/JCDR/2020/44366.13958  [Google Scholar]  [CrossRef]